Envoy Medical

Envoy Medical is a commercial-stage medical device company focused on addressing hearing loss through fully implanted devices, eliminating the need for daily external components. Its commercial product, the Esteem FI-AMEI, serves patients with sensorineural hearing loss, while its investigational Acclaim cochlear implant system is in a pivotal trial for severe-to-profound hearing loss. The company aims to capture share in the large and underpenetrated global hearing loss market by offering a differentiated, implantable solution that improves quality of life and user convenience compared to traditional hearing aids and other implants.

Fully implanted hearing systems utilizing a proprietary piezoelectric sensor that uses the ear's natural tympanic membrane to pick up sound, enabling active middle ear stimulation or cochlear implantation without daily external components.

Envoy competes in the broader hearing restoration market against giant hearing aid companies (e.g., Sonova, Demant) and established cochlear implant manufacturers (e.g., Cochlear Limited, Advanced Bionics). Its primary competitive edge is the fully implanted design, but it faces challenges in scale, brand recognition, and competing with lower-cost, non-invasive options.